Ingevity's Q3 2025 results showcased strong execution, with significant strategic milestones, including the announcement of the $110 million sale of its Industrial Specialties business and an impressive 33% EBITDA margin, marking a sixth consecutive quarter of margin expansion.

• Total sales decreased by 4% to $362 million, driven by declines in Industrial Specialties and APT, despite growth in Performance Materials and Road Technologies.
• Adjusted EBITDA reached $56.3 million, up nearly 500 basis points, resulting in an EBITDA margin of 33.5%.
• Strong free cash flow of $118 million enabled $25 million in share repurchases and ahead-of-target debt reduction, bringing net leverage down to 2.7x.
• Performance Materials displayed volume growth with 3% sales increase, while APT faced continued pressure from tariffs and competitive dynamics, anticipating a mid-teen revenue decline for the full year.